Key result
The use of venovenous and venoarterial ECMO during pregnancy and the postpartum period has increased, with reassuring data for VV ECMO but extremely limited data for VA ECMO.
Why the study?
Use of VV and VA ECMO during pregnancy and postpartum has increased, but data on the use of VA ECMO during pregnancy remain extremely limited.
While VV ECMO use during pregnancy has increased with reassuring data, evidence for VA ECMO in this population remains extremely limited.
Answers are grounded in this paper and cite their sources.
ECMO use is rising in pregnancy and postpartum; leaves open need for dedicated safety and outcome data.
In the last 2 decades, the use of venovenous (VV) and venoarterial (VA) extracorporeal membrane oxygenation (ECMO) during pregnancy and the postpartum period has increased, mirroring the increased utilization in nonpregnant individuals worldwide. VV ECMO provides respiratory support for patients with acute respiratory distress syndrome (ARDS) who fail conventional mechanical ventilation. With the COVID-19 pandemic, the use of VV ECMO has increased dramatically and data during pregnancy and the postpartum period are overall reassuring. In contrast, VA ECMO provides both respiratory and cardiovascular support. Data on the use of VA ECMO during pregnancy are extremely limited.
No takes yet. Share an insight, caveat, or question.
Pacheco et al. (2022) conducted a review in Pregnancy and postpartum period requiring ECMO. Extracorporeal Membrane Oxygenation (VV and VA ECMO) was evaluated. The use of venovenous and venoarterial ECMO during pregnancy and the postpartum period has increased, with reassuring data for VV ECMO but extremely limited data for VA ECMO.
Synapse has enriched 10 related papers. Consider them for comparative context: